Portfolio company
Pexa
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops non-invasive instruments to collect biomarkers from exhaled air for respiratory disease research and diagnosis for pharmaceutical firms, hospitals and academic institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avelo
This company develops non-invasive breath sampling kits for the molecular diagnosis of respiratory infections like tuberculosis and pneumonia for clinicians and patients.
Anaxsys
This medical technology company develops respiratory monitoring devices and lung cancer screening tools for healthcare professionals and clinical settings.
Apieron
This company develops biosensor devices to monitor exhaled nitric oxide for asthma management in patients and clinical settings.
Respira
This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.
Nebu-Flow
The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Prothea
This company develops integrated microendoscope and laser ablation systems for the diagnosis and treatment of lung cancer in a single hospital visit.
Swaza
This biotechnology firm develops nanofluid breathing aids and oxygen-enriched biomaterials for patients suffering from respiratory distress, chronic lung diseases, and severe wounds.
